製品の概要

製品の詳細

  • 由来Synthetic

関連製品

特性

Our Abpromise guarantee covers the use of ab42682 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • アプリケーション

    Blocking - Blocking peptide for Anti-EAAT1 antibody (ab41751)

  • 製品の状態Liquid
  • 備考

    - First try to dissolve a small amount of peptide in either water or buffer. The more charged residues on a peptide, the more soluble it is in aqueous solutions.
    - If the peptide doesn’t dissolve try an organic solvent e.g. DMSO, then dilute using water or buffer.
    - Consider that any solvent used must be compatible with your assay. If a peptide does not dissolve and you need to recover it, lyophilise to remove the solvent.
    - Gentle warming and sonication can effectively aid peptide solubilisation. If the solution is cloudy or has gelled the peptide may be in suspension rather than solubilised.
    - Peptides containing cysteine are easily oxidised, so should be prepared in solution just prior to use.

  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Information available upon request.

関連情報

  • 別名
    • EA6
    • EAA1_HUMAN
    • EAAT1
    • Excitatory amino acid transporter 1
    • FLJ25094
    • GLAST
    • GLAST-1
    • GLAST1
    • Glial high affinity glutamate transporter
    • glutamate/aspartate transporter, high affinity, sodium-dependent
    • High affinity neuronal glutamate transporter
    • Slc1a3
    • Sodium dependent glutamate/aspartate transporter
    • Sodium-dependent glutamate/aspartate transporter 1
    • Solute carrier family 1 (glial high affinity glutamate transporter) member 3
    • Solute carrier family 1 member 3
    see all
  • 機能Transports L-glutamate and also L- and D-aspartate. Essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. Acts as a symport by cotransporting sodium.
  • 組織特異性Highly expressed in cerebellum, but also found in frontal cortex, hippocampus and basal ganglia.
  • 関連疾患Defects in SLC1A3 are the cause of episodic ataxia type 6 (EA6) [MIM:612656]. EA6 is characterized by episodic ataxia, seizures, migraine and alternating hemiplegia.
  • 配列類似性Belongs to the sodium:dicarboxylate (SDF) symporter (TC 2.A.23) family. SLC1A3 subfamily.
  • 翻訳後修飾Glycosylated.
  • 細胞内局在Membrane.
  • Information by UniProt

Human EAAT1 peptide (ab42682) 使用論文

ab42682 has not yet been referenced specifically in any publications.

Product Wall

Thank you for contacting us.

Unfortunately the blocking peptide is not available so I am sorry we are unable to with this inquiry.

I hope this information is nevertheless helpful to you. Please do not hesitate to contact us if you nee...

Read More

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"